132
Participants
Start Date
March 2, 2023
Primary Completion Date
September 29, 2023
Study Completion Date
September 29, 2023
TNX-601 ER
Patients will take 1 tablet orally once daily for 6 weeks.
Placebo
Patients will take 1 tablet orally once daily for 6 weeks.
Cenexel Research - Decatur, Decatur
Cenexel ACMR - Atlanta, Atlanta
Clinical Neuroscience Solutions - Jacksonville, Jacksonville
Clinical Neuroscience Solutions - Orlando, Orlando
Segal Trials - North Miami, Miami Lakes
West Broward Outpatient Clinic, Lauderhill
Gulfcoast Clinical Research Center, Fort Myers
Clinical Neuroscience Solutions - Memphis, Memphis
Chicago Research Center, Chicago
Preferred Research Partners, Little Rock
Futuresearch Trials of Dallas, Dallas
Donald J. Garcia, Jr., Austin
Mountain View Clinical Research, Denver
Northwest Clinical Trials, Boise
Cenexel CIT - Bellflower, Bellflower
Behavioral Research Specialists, Glendale
Cenexel CNR - Sherman Oaks, Sherman Oaks
Synergy Research, Lemon Grove
Excell Research, Oceanside
Artemis Institute for Clinical Research, San Diego
Cenexel CIT - Riverside, Riverside
NCR Research Institute, Orange
Viking Clinical Research, Temecula
Summit Research Network, Portland
Core Clinical Research, Everett
CT Clinical Research Associates, Cromwell
Cenexel HRI - Berlin, Berlin
Rho, Inc.
INDUSTRY
Tonix Pharmaceuticals, Inc.
INDUSTRY